NCT04260802 2026-01-12A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersOcellaris Pharma, Inc.Phase 1/2 Terminated73 enrolled
NCT04725331 2025-11-21A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsTransgenePhase 1/2 Terminated31 enrolled
NCT03901573 2025-10-22High-Risk Skin Cancers With Atezolizumab Plus NT-I7NeoImmuneTechPhase 1/2 Terminated31 enrolled 12 charts
NCT04272034 2025-10-16Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated105 enrolled
NCT04458259 2025-08-28Study of PF-07265807 in Participants With Metastatic Solid Tumors.PfizerPhase 1 Terminated88 enrolled